Skip to content
★ Sign in to follow
PF

Paulo F. Costa

CorMedix Inc.Macrogenics IncAmylin Pharmaceuticals Inc
Total declarations
13
Companies
3
▲ Purchases (2 ops.)
€201k
▼ Sales (0 ops.)
—

Latest filing published 17 May 2023 for CorMedix Inc., €43k.

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

Closed purchases

Market purchases
2

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 04 Mar 2016 · 3902 days ago · €158k
    +1.2%
    Entry US$19.47 · Close at T+365 US$19.71

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Paulo F. Costa: trading record in brief

This profile gathers the share dealings of Paulo F. Costa across 3 companies, led by Amylin Pharmaceuticals Inc, CorMedix Inc. and Macrogenics Inc. In total, 13 filings cover trades dated from 24 May 2011 to 17 May 2023.

The open-market record is one-sided, with 2 purchases worth €201k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 9 share grants. Since January 2023: 1 purchase and no sales on the market.

The newest entry dates from 18 May 2023: an open-market purchase of €43k, in CorMedix Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Paulo F. Costa

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations12 total

12 of 12 declarations